Pediatrix Medical Statistics Share Statistics Pediatrix Medical has 87.08M
shares outstanding. The number of shares has increased by 0.05%
in one year.
Shares Outstanding 87.08M Shares Change (YoY) 0.05% Shares Change (QoQ) 0.09% Owned by Institutions (%) 93.49% Shares Floating 84.22M Failed to Deliver (FTD) Shares 28 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 2.39M, so 2.75% of the outstanding
shares have been sold short.
Short Interest 2.39M Short % of Shares Out 2.75% Short % of Float 3.84% Short Ratio (days to cover) 3.25
Valuation Ratios The PE ratio is -11.04 and the forward
PE ratio is 8.93.
Pediatrix Medical's PEG ratio is
-0.17.
PE Ratio -11.04 Forward PE 8.93 PS Ratio 0.54 Forward PS 0.7 PB Ratio 1.43 P/FCF Ratio 5.92 PEG Ratio -0.17
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Pediatrix Medical.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.47,
with a Debt / Equity ratio of 0.87.
Current Ratio 1.47 Quick Ratio 1.47 Debt / Equity 0.87 Debt / EBITDA -23.34 Debt / FCF 3.59 Interest Coverage -1.69
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $488.57K Profits Per Employee $-24.05K Employee Count 4,120 Asset Turnover 0.94 Inventory Turnover n/a
Taxes Income Tax -2.27M Effective Tax Rate 2.24%
Stock Price Statistics The stock price has increased by 44.85% in the
last 52 weeks. The beta is 1.3, so Pediatrix Medical's
price volatility has been higher than the market average.
Beta 1.3 52-Week Price Change 44.85% 50-Day Moving Average 15.31 200-Day Moving Average 14.26 Relative Strength Index (RSI) 50.7 Average Volume (20 Days) 758,134
Income Statement In the last 12 months, Pediatrix Medical had revenue of 2.01B
and earned -99.07M
in profits. Earnings per share was -1.19.
Revenue 2.01B Gross Profit 454.34M Operating Income -68.71M Net Income -99.07M EBITDA -28.37M EBIT -60.6M Earnings Per Share (EPS) -1.19
Full Income Statement Balance Sheet The company has 229.94M in cash and 662.31M in
debt, giving a net cash position of -432.37M.
Cash & Cash Equivalents 229.94M Total Debt 662.31M Net Cash -432.37M Retained Earnings -248.54M Total Assets 2.1B Working Capital 272.01M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 206.57M
and capital expenditures -22.02M, giving a free cash flow of 184.55M.
Operating Cash Flow 206.57M Capital Expenditures -22.02M Free Cash Flow 184.55M FCF Per Share 2.21
Full Cash Flow Statement Margins Gross margin is 22.57%, with operating and profit margins of -3.41% and -4.92%.
Gross Margin 22.57% Operating Margin -3.41% Pretax Margin -5.03% Profit Margin -4.92% EBITDA Margin -1.41% EBIT Margin -3.41% FCF Margin 9.17%
Dividends & Yields MD does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for MD is $16.5,
which is 1.2% higher than the current price. The consensus rating is "Hold".
Price Target $16.5 Price Target Difference 1.2% Analyst Consensus Hold Analyst Count 7
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Dec 20, 2013. It was a
forward
split with a ratio of 2:1.
Last Split Date Dec 20, 2013 Split Type forward Split Ratio 2:1
Scores Altman Z-Score 1.92 Piotroski F-Score 8
